The Department of Health (DOH) cited a study published by a US-based journal stating that ivermectin is “not a viable option” to treat Covid-19 patients.
The Clinical Infectious Diseases, the official publication of the Infectious Diseases Society of America, concluded in its study that “in comparison to SOC (standard of care) or placebo, IVM (ivermectin) did not reduce all-cause mortality, length of stay or viral clearance in RCTs (randomised controlled trials) in Covid-19 patients with mostly mild disease”.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
